+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Age: 18Years - 75Years
All Genders
ID07515014

Evaluating E6742 Oral Tablets Compared to Placebo for Systemic Lupus Erythematosus Treatment A Phase 2 Randomized, Double-Blind, Multicenter Dose-Response Study

Led by Eisai Co., Ltd. · Updated on 2026-08-21

256

Participants Needed

54

Research Sites

29 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the effect of E6742, an oral drug, compared with a placebo in adults with systemic lupus erythematosus SLE. This phase 2, randomized, double-blind, placebo-controlled study aims to assess how different doses of E6742 influence the proportion of participants achieving a response using the British Isles Lupus Assessment Group BILAG based Composite Lupus Assessment BICLA while using a low dose of oral corticosteroids at Week 24. Participants will be randomly assigned to receive one of several doses of E6742 or a placebo in oral tablet form. The treatment period involves administering these doses while monitoring participants for up to 24 weeks. The study evaluates the efficacy based on dose response, as well as safety measures including adverse events, laboratory tests, vital signs, and various clinical assessments during this time. Throughout the study, participants will undergo multiple evaluations including clinical assessments like SLEDAI-2K, BILAG-2004, patient-reported outcomes, and laboratory tests such as autoantibody levels and complements. Safety will be monitored via vital signs, ECGs, ophthalmic exams, and chest X-rays. The primary outcome is measured at Week 24, with safety and secondary outcomes assessed up to 52 weeks. Participants are expected to comply with study visits and treatments over this period.

CONDITIONS

Brief Title

A Study of E6742 in Participants With Systemic Lupus Erythematosus

Research Team

E

Eisai Medical Information

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here